STSS
Sharps Technology Inc
NASDAQ: STSS · HEALTHCARE · MEDICAL INSTRUMENTS & SUPPLIES
$1.79
+2.00% today
Updated 2026-04-30
Market cap
$69.21M
P/E ratio
—
P/S ratio
339.06x
EPS (TTM)
$-10.68
Dividend yield
—
52W range
$1 – $18
Volume
0.3M
Sharps Technology Inc (STSS) Financial statements
SEC filings — annual and quarterly data.
Income statement — annual
| Item | 2007 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $336995.00 | — | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $204120.00 |
| Revenue growth (YoY) | — | -100.0% | — | — | — | — | — | — |
| Cost of revenue | $145425.00 | $10587.00 | $11038.00 | $28699.00 | $654572.00 | $891248.00 | $773904.00 | $617445.00 |
| Gross profit | $191570.00 | $-10587.00 | $-11038.00 | $-28699.00 | $-654572.00 | $-891248.00 | $-773904.00 | $-413325.00 |
| Gross margin | 56.8% | — | — | — | — | — | — | -202.5% |
| R&D | $284722.00 | $388020.00 | $827005.00 | $1.69M | $1.63M | $729483.00 | $58025.00 | $198762.00 |
| SG&A | — | $1.51M | $1.51M | $2.81M | $6.46M | $8.52M | $7.15M | $19.49M |
| Operating income | $-3.28M | $-2.06M | $-2.33M | $-4.50M | $-8.74M | $-10.13M | $-7.86M | $-13.29M |
| Operating margin | -973.1% | — | — | — | — | — | — | -6512.1% |
| EBITDA | $-2.96M | $-2.04M | $-2.33M | $-4.47M | $-2.66M | $-8.98M | $-6.85M | $-269.74M |
| EBITDA margin | -877.2% | — | — | — | — | — | — | -132145.5% |
| EBIT | $-3.28M | $-2.06M | $-2.34M | $-4.50M | $-3.32M | $-9.87M | $-7.62M | $-269.87M |
| Interest expense | — | $0.00 | $3333.00 | $167515.00 | $1.32M | $138118.00 | $1.71M | $416660.00 |
| Income tax | — | — | — | — | — | — | — | — |
| Effective tax rate | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net income | $-3.29M | $-2.06M | $-2.35M | $-4.66M | $-4.64M | $-9.84M | $-9.30M | $-282.50M |
| Net income growth (YoY) | — | +37.5% | -14.2% | -98.7% | +0.5% | -112.1% | +5.5% | -2938.9% |
| Profit margin | -975.2% | — | — | — | — | — | — | -138400.0% |